| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2009.04.058 |
| P698 | PubMed publication ID | 19406183 |
| P2093 | author name string | A Priadi | |
| E E Worrall | |||
| Sudarisman | |||
| P2860 | cites work | Production of the Pseudomonas aeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression | Q40343721 |
| Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract | Q43176503 | ||
| Antigen transmission by replicating antigen-bearing dendritic cells. | Q50669182 | ||
| Structural biology: Antiviral drugs fit for a purpose | Q58979755 | ||
| Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice | Q72410226 | ||
| Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers | Q24545856 | ||
| Structure and mechanism of the M2 proton channel of influenza A virus | Q24625464 | ||
| Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B | Q27749017 | ||
| Controlling influenza by inhibiting the virus's neuraminidase. | Q27863788 | ||
| Rational design of potent sialidase-based inhibitors of influenza virus replication | Q29616647 | ||
| Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection | Q30328172 | ||
| Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. | Q30332972 | ||
| The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. | Q30356303 | ||
| Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects | Q34334155 | ||
| The M2 proton channels of influenza A and B viruses | Q34483647 | ||
| Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity | Q34565520 | ||
| Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production | Q34803233 | ||
| Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase | Q36617502 | ||
| microRNAs and the immune response | Q37178538 | ||
| P433 | issue | 31 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | avian influenza | Q43987 |
| P304 | page(s) | 4161-4168 | |
| P577 | publication date | 2009-05-09 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry | |
| P478 | volume | 27 |
| Q45365634 | A lack of antibody formation against inactivated influenza virus after aerosol vaccination in presence or absence of adjuvantia. |
| Q38031950 | Induction of respiratory immune responses in the chicken; implications for development of mucosal avian influenza virus vaccines. |
| Q37703366 | Preparation of mucosal nanoparticles and polymer-based inactivated vaccine for Newcastle disease and H9N2 AI viruses |
Search more.